asimadoline has been researched along with nalorphine in 1 studies
Studies (asimadoline) | Trials (asimadoline) | Recent Studies (post-2010) (asimadoline) | Studies (nalorphine) | Trials (nalorphine) | Recent Studies (post-2010) (nalorphine) |
---|---|---|---|---|---|
43 | 9 | 11 | 1,134 | 41 | 6 |
Protein | Taxonomy | asimadoline (IC50) | nalorphine (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
1 other study(ies) available for asimadoline and nalorphine
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |